Dr.ย Raananย Berger
MD, PhD
Director, Division of Cancer Medicine & Head of Cancer Center
corporate_fareSheba Medical Center, Tel Hashomer, Israel
Raanan Berger
MD, PhD
Prof. Raanan Berger is one of Israel's leading cancer specialists, serving as Head of the Cancer Center and Director of the Division of Cancer Medicine at Sheba Medical Center, Tel Hashomer. His primary clinical focus is genitourinary oncology โ covering prostate, bladder, kidney, and testicular cancers โ combined with expertise in radiotherapy and oncology clinical research.
Prof. Berger holds MD and PhD degrees from Tel Aviv University's Sackler Faculty of Medicine and completed postdoctoral fellowship training at Dana-Farber Cancer Institute, Harvard Medical School. He led Sheba's oncology system from 2011 to 2022, and during that period founded Israel's first Phase I oncology clinical research unit focused on drug development. He also runs a translational research laboratory investigating molecular mechanisms in prostate and breast tumorigenesis. Tel Aviv University lists over 111 research outputs associated with him, and Sheba has recognised him as a Forbes Outstanding Physician. His practice spans systemic therapy, radiation oncology, brachytherapy, and investigational treatments delivered through major clinical trials at the Riva Koschitzky Oncology Clinical Research Unit.
CancerFax can coordinate medical-record review, second-opinion support, and consultation assistance for international patients seeking care from Prof. Berger at Sheba Medical Center.
Why Consider Prof. Raanan Berger?
Prof. Berger combines deep clinical expertise in genitourinary oncology with a strong track record in translational research and early-phase clinical trials at one of Israel's foremost cancer centres.
Areas of Specialisation
Focused clinical expertise in genitourinary oncology, radiotherapy, and oncology clinical research
Prof. Berger's practice centres on genitourinary malignancies and systemic oncology, supported by a translational research programme and leadership of Sheba's clinical trials infrastructure.
Genitourinary Oncology
Comprehensive clinical management of urological and genital tract cancers, from diagnosis through systemic and radiation-based treatment planning.
- arrow_rightMedical oncology management of localised and advanced prostate cancer
- arrow_rightTranslational research in prostate tumorigenesis and molecular mechanisms
- arrow_rightIntegration of targeted, hormonal, and systemic treatment approaches
- arrow_rightSystemic therapy planning for bladder and renal cell carcinoma
- arrow_rightParticipation in renal cell carcinoma phase III research including the CLEAR study
- arrow_rightMultidisciplinary treatment planning for complex cases
- arrow_rightMedical oncology management of testicular germ cell tumours
- arrow_rightChemotherapy protocols and monitoring for eligible patients
Radiotherapy & Brachytherapy
Combined medical oncology and radiotherapy expertise enables integrated treatment planning for patients requiring both systemic and radiation-based approaches.
- arrow_rightRadiotherapy planning and delivery for selected cancer indications
- arrow_rightCombined chemoradiation protocols for eligible patients
- arrow_rightInternal radiation therapy for appropriate candidates
- arrow_rightIntegration with systemic oncology treatment plans
Oncology Clinical Trials
Leadership of Sheba's clinical research infrastructure, providing eligible patients with access to early-phase and advanced oncology trials.
- arrow_rightFounder of Israel's first Phase I oncology drug development unit at Sheba
- arrow_rightTrial access for patients with advanced or refractory cancers
- arrow_rightInvestigational therapies across genitourinary and other malignancies
Procedures Performed
Clinical services spanning systemic oncology, radiotherapy, and investigational research
Prof. Berger's clinical services combine medical oncology, radiotherapy, and trial-based therapies for patients with genitourinary and other cancers at Sheba Medical Center.
Medical Oncology
Medical OncologySystemic cancer treatment planning and administration for genitourinary and other malignancies.
Radiotherapy & Brachytherapy
MultidisciplinaryRadiation-based treatment approaches integrated with systemic oncology care.
Clinical Trials & Investigational Therapy
Complex DiseaseAccess to early-phase and advanced clinical trials through the Riva Koschitzky Oncology Clinical Research Unit at Sheba Medical Center.
Second Opinion
Second OpinionExpert review of pathology, imaging, and treatment plans for patients with complex genitourinary cancers seeking an independent specialist assessment.
Research & Publications
Translational oncology research and peer-reviewed contributions
Prof. Berger has contributed extensively to oncology research, with Tel Aviv University listing over 111 research outputs. His work spans prostate cancer biology, renal cell carcinoma clinical trials, and translational research in genitourinary malignancies.
A full publication list is available through Tel Aviv University's institutional research portal and PubMed.
Education & Training
Prof. Berger completed his MD and PhD at Tel Aviv University's Sackler Faculty of Medicine and underwent oncology and radiotherapy specialisation at Sheba Medical Center, followed by postdoctoral fellowship training at Dana-Farber Cancer Institute, Harvard Medical School.
Clinical Experience
Prof. Berger has held senior oncology leadership roles at Sheba Medical Center for more than a decade, progressing from Head of the Oncology System and Clinical Research Department to Director of the Division of Cancer Medicine, a role he has held since 2022.
Languages & International
Prof. Berger consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting at Sheba Medical Center.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Raanan Berger
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Raanan Berger's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Raanan Berger's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Raanan Berger before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Raanan Berger's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Raanan Berger's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Raanan Berger's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Raanan Berger
Prof. Raanan Berger specialises in genitourinary oncology, including prostate cancer, bladder cancer, kidney cancer (renal cell carcinoma), and testicular cancer. He also has clinical expertise in radiotherapy and brachytherapy for relevant cancer types.
CancerFax can coordinate medical-record review and consultation support for international patients seeking an opinion from Prof. Berger at Sheba Medical Center, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case, and coordinate the next steps with Sheba Medical Center, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. The final consultation format and availability depend on the doctor's schedule at Sheba Medical Center.
Yes. Prof. Berger founded Israel's first Phase I oncology drug development unit at Sheba Medical Center and leads the Riva Koschitzky Oncology Clinical Research Unit, which hosts more than 200 advanced clinical trials. Patients with advanced or refractory cancers may be eligible for trial participation, subject to eligibility criteria and availability.
Prof. Berger holds MD and PhD degrees from Tel Aviv University's Sackler Faculty of Medicine and completed postdoctoral fellowship training at Dana-Farber Cancer Institute, Harvard Medical School. He undertook his oncology and radiotherapy specialisation at Sheba Medical Center.
Connect with Raanan Berger Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.